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Partial lipodystrophy (PL) is characterized by a slow and symmetrical loss of 
subcutaneous fatty tissue, mainly involving the upper half of the body. We report a case 
of PL associated with dermatomyositis. 
 
 
REPORT OF A CASE 
 
In 1978, an 11-year-old boy began to notice proximal weakness in his limbs together 
with facial erythema; palpebral violaceous edema; and erythematous papules on his 
elbows, knees, and over the metacarpophalangeal joints. A diagnosis of 
polymyositis/dermatomyositis was made. He was treated with oral prednisone, which 
caused the symptoms to disappear promptly. In 1980, proximal weakness, dysphagia, 
clyspnea, and similar cutaneous lesions once again developed. Muscular wasting and 
slight articular retractions were evident. Laboratory values at that time showed the 
following values or results: aspartate aminotransferase, 122 U/L (normal, 0 to 40 U/L); 
alanine aminotransferase, 140 U/L (normal, 0 to 40 U/L); creatine phosphokinase, 303 
U/L (normal, 0 to 200 U/L); aldolase, 2.5 U/L (normal, 0.8 to 1.9 U/L); lactic 
dehydrogenase, greater than 1500 U/L (normal, 230 to 460 U/L); creatinine clearance, 
55 mL/min (normal, 88 to 120 mL/min); antinuclear antibodies, positive at 1/320 with a 
homogeneous pattern; anti-DNA, anti—Sjögren syndrome A, anti—Sjögren syndrome 
B, and anti—ribonucleoprotein antibodies, negative; C3 and C4, normal; CH50, normal; 
circulating immune complexes, not detectable by the Raji cell test; and serology to 
Toxoplasma, negative. 
 
Results from the electromyogram and the findings from the muscular biopsy specimen 
were typical of polymyositis. The patient was sent to our department for treatment and 
follow-up. He received a course of oral prednisone and azathioprine, which controlled 
the disease. Moreover, on clinical examination, we found a loss of buccal fat, the eyes 
were deep set, and numerous fine rhytids appeared when the patient smiled. Although 
muscular waste was evident, he had a pseudohypertrophic appearance. The superficial 
veins were patent (Figure). These changes were present in the upper half of his body, 
while no abnormalities were present in the lower half. A deep-skin biopsy specimen 
from the patient's left arm showed a complete absence of subcutaneous and periadnexal 
fatty tissue. The patient could not ascertain with accuracy when these changes began, 
and he thought they were present from early childhood. No familial records were 
available. He has undergone follow-up in our department, and, on the last visit, in 1990, 
no changes had appeared. All throughout this period, complement levels, renal function 
studies, glycemia, urinalysis, and C3 nephritic factor determinations have been normal 
or negative. 
COMMENT 
 
Multiple, patchy, nonsymmetrical lesions typical of localized lipoatrophy have been 
reported together with dermatomyositis
1
 and also myositis and muscular atrophy.
2
 
Localized lipoatrophy may represent an end stage of panniculitis.
3
 Thus, although 
panniculitis is rare in dermatomyositis,
1
  it may account for localized lipoatrophy. In 
contrast, our patient represents the first case reported of dermatomyositis and PL. 
 
The pathogenesis of PL is unknown. Its association with gate disorders such as 
Sjögren's syndrome, lupus erythematosus, and autoimmune thyroid disease suggests 
an immunologic basis.
4
 In addition, some patients have mesangiocapillary 
glomerulonephritis, C3 hypocomplementemia, and the presence of C3 nephritic factor. 
A role for circulating immune complexes has been proposed for this association.
4
 On 
the other hand, other authors explain PL on a neurologic or endocrinologic basis.
4
 
Pathogenesis of dermatomyositis is equally unknown, but immunologic disturbances 
such as circulating autoantibodies and immune complexes may be strongly involved.
5
  
 
Although we cannot state that the association of PL and dermatomyositis is accidental, 
the immunologic background of both diseases may point to some common pathogenetic 
mechanisms. 
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A general view of the patient 
